PARTNERSHIP ESTABLISHED WITH A LEADING CHINESE ONCOLOGY CENTER IN THE FIELD OF CELL THERAPY

The National Biopharmaceutical Research Institute of the Republic of Uzbekistan has established a partnership with Beijing Cancer Hospital, one of the leading medical institutions in the People's Republic of China specializing in the treatment of cancer through advanced cell therapy technologies, particularly CAR-T (Chimeric Antigen Receptor T-cell) therapy.

Within the framework of this cooperation, the parties reached an agreement to study advanced scientific practices in the field of cell therapy, promote joint research projects, enhance the professional qualifications of specialists, and facilitate the implementation of innovative biotechnologies.

During the meeting, a representative of Beijing Cancer Hospital delivered a comprehensive presentation on the role of CAR-T cell therapy in the treatment of cancer, highlighting the latest scientific achievements in the field as well as China's practical experience in applying this innovative technology.

This partnership represents an important milestone in advancing cell therapy and modern biotechnologies at the National Biopharmaceutical Research Institute, expanding international scientific collaboration, and introducing innovative solutions in the field of oncology.